Implications of pharmacogenomics for anesthesia providers

Tori Ama, Sou Bounmythavong, Jodee Blaze, Melissa Weismann, Mary Shirk Marienau, Wayne T. Nicholson

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

The practice of anesthesia has long been considered an art and a science, with interpatient variability in drug response being the rule, rather than the exception. Pharmacogenomics, which studies the role of genetics in drug response, is emerging as a discipline that may impact anesthetic management. The purpose of this review is to provide clinicians with basic knowledge related to pharmacogenomics and its implications in anesthesia. This review focuses on pharmacogenomics related to commonly used drugs in anesthesia. Pharmacogenomics as a predictor of drug response is increasingly used in medicine and drug development. By expanding the knowledge base of anesthesia providers, pharmacogenomic considerations have the potential to improve therapeutic outcomes and individualize drug therapy, while avoiding toxic effects and treatment failure. However, because pharmacogenomics may not fully explain variability in drug response, implementation should be in conjunction with traditional anesthesia considerations.

Original languageEnglish (US)
Pages (from-to)393-399
Number of pages7
JournalAANA Journal
Volume78
Issue number5
StatePublished - Oct 2010

Fingerprint

Pharmacogenetics
Anesthesia
Pharmaceutical Preparations
Knowledge Bases
Poisons
Art
Treatment Failure
Anesthetics
Medicine
Drug Therapy

Keywords

  • Anesthesia
  • Drug variability
  • Pharmacogenetics
  • Pharmacogenomics
  • Polymorphisms

ASJC Scopus subject areas

  • Anesthesiology and Pain Medicine
  • Medical–Surgical
  • Advanced and Specialized Nursing

Cite this

Ama, T., Bounmythavong, S., Blaze, J., Weismann, M., Marienau, M. S., & Nicholson, W. T. (2010). Implications of pharmacogenomics for anesthesia providers. AANA Journal, 78(5), 393-399.

Implications of pharmacogenomics for anesthesia providers. / Ama, Tori; Bounmythavong, Sou; Blaze, Jodee; Weismann, Melissa; Marienau, Mary Shirk; Nicholson, Wayne T.

In: AANA Journal, Vol. 78, No. 5, 10.2010, p. 393-399.

Research output: Contribution to journalArticle

Ama, T, Bounmythavong, S, Blaze, J, Weismann, M, Marienau, MS & Nicholson, WT 2010, 'Implications of pharmacogenomics for anesthesia providers', AANA Journal, vol. 78, no. 5, pp. 393-399.
Ama T, Bounmythavong S, Blaze J, Weismann M, Marienau MS, Nicholson WT. Implications of pharmacogenomics for anesthesia providers. AANA Journal. 2010 Oct;78(5):393-399.
Ama, Tori ; Bounmythavong, Sou ; Blaze, Jodee ; Weismann, Melissa ; Marienau, Mary Shirk ; Nicholson, Wayne T. / Implications of pharmacogenomics for anesthesia providers. In: AANA Journal. 2010 ; Vol. 78, No. 5. pp. 393-399.
@article{42dbc8743d004b588118a3188518f8d9,
title = "Implications of pharmacogenomics for anesthesia providers",
abstract = "The practice of anesthesia has long been considered an art and a science, with interpatient variability in drug response being the rule, rather than the exception. Pharmacogenomics, which studies the role of genetics in drug response, is emerging as a discipline that may impact anesthetic management. The purpose of this review is to provide clinicians with basic knowledge related to pharmacogenomics and its implications in anesthesia. This review focuses on pharmacogenomics related to commonly used drugs in anesthesia. Pharmacogenomics as a predictor of drug response is increasingly used in medicine and drug development. By expanding the knowledge base of anesthesia providers, pharmacogenomic considerations have the potential to improve therapeutic outcomes and individualize drug therapy, while avoiding toxic effects and treatment failure. However, because pharmacogenomics may not fully explain variability in drug response, implementation should be in conjunction with traditional anesthesia considerations.",
keywords = "Anesthesia, Drug variability, Pharmacogenetics, Pharmacogenomics, Polymorphisms",
author = "Tori Ama and Sou Bounmythavong and Jodee Blaze and Melissa Weismann and Marienau, {Mary Shirk} and Nicholson, {Wayne T.}",
year = "2010",
month = "10",
language = "English (US)",
volume = "78",
pages = "393--399",
journal = "AANA Journal",
issn = "0094-6354",
publisher = "AANA Publishing Inc.",
number = "5",

}

TY - JOUR

T1 - Implications of pharmacogenomics for anesthesia providers

AU - Ama, Tori

AU - Bounmythavong, Sou

AU - Blaze, Jodee

AU - Weismann, Melissa

AU - Marienau, Mary Shirk

AU - Nicholson, Wayne T.

PY - 2010/10

Y1 - 2010/10

N2 - The practice of anesthesia has long been considered an art and a science, with interpatient variability in drug response being the rule, rather than the exception. Pharmacogenomics, which studies the role of genetics in drug response, is emerging as a discipline that may impact anesthetic management. The purpose of this review is to provide clinicians with basic knowledge related to pharmacogenomics and its implications in anesthesia. This review focuses on pharmacogenomics related to commonly used drugs in anesthesia. Pharmacogenomics as a predictor of drug response is increasingly used in medicine and drug development. By expanding the knowledge base of anesthesia providers, pharmacogenomic considerations have the potential to improve therapeutic outcomes and individualize drug therapy, while avoiding toxic effects and treatment failure. However, because pharmacogenomics may not fully explain variability in drug response, implementation should be in conjunction with traditional anesthesia considerations.

AB - The practice of anesthesia has long been considered an art and a science, with interpatient variability in drug response being the rule, rather than the exception. Pharmacogenomics, which studies the role of genetics in drug response, is emerging as a discipline that may impact anesthetic management. The purpose of this review is to provide clinicians with basic knowledge related to pharmacogenomics and its implications in anesthesia. This review focuses on pharmacogenomics related to commonly used drugs in anesthesia. Pharmacogenomics as a predictor of drug response is increasingly used in medicine and drug development. By expanding the knowledge base of anesthesia providers, pharmacogenomic considerations have the potential to improve therapeutic outcomes and individualize drug therapy, while avoiding toxic effects and treatment failure. However, because pharmacogenomics may not fully explain variability in drug response, implementation should be in conjunction with traditional anesthesia considerations.

KW - Anesthesia

KW - Drug variability

KW - Pharmacogenetics

KW - Pharmacogenomics

KW - Polymorphisms

UR - http://www.scopus.com/inward/record.url?scp=78049268990&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78049268990&partnerID=8YFLogxK

M3 - Article

C2 - 21067087

AN - SCOPUS:78049268990

VL - 78

SP - 393

EP - 399

JO - AANA Journal

JF - AANA Journal

SN - 0094-6354

IS - 5

ER -